343 related articles for article (PubMed ID: 23846544)
1. Behavioral and neurochemical characterization of kratom (Mitragyna speciosa) extract.
Stolt AC; Schröder H; Neurath H; Grecksch G; Höllt V; Meyer MR; Maurer HH; Ziebolz N; Havemann-Reinecke U; Becker A
Psychopharmacology (Berl); 2014 Jan; 231(1):13-25. PubMed ID: 23846544
[TBL] [Abstract][Full Text] [Related]
2. The effects of kratom on restraint-stress-induced analgesia and its mechanisms of action.
Vázquez López JL; Schild L; Günther T; Schulz S; Neurath H; Becker A
J Ethnopharmacol; 2017 Jun; 205():178-185. PubMed ID: 28501425
[TBL] [Abstract][Full Text] [Related]
3. Abuse liability and therapeutic potential of the Mitragyna speciosa (kratom) alkaloids mitragynine and 7-hydroxymitragynine.
Hemby SE; McIntosh S; Leon F; Cutler SJ; McCurdy CR
Addict Biol; 2019 Sep; 24(5):874-885. PubMed ID: 29949228
[TBL] [Abstract][Full Text] [Related]
4. Endogenous Opioid Activity as the Mechanism of Action for Mitragyna speciosa (Kratom): The Current State of the Evidence.
Bowe A; Kerr PL
Adv Neurobiol; 2024; 35():287-313. PubMed ID: 38874729
[TBL] [Abstract][Full Text] [Related]
5. Lyophilized Kratom Tea as a Therapeutic Option for Opioid Dependence.
Wilson LL; Harris HM; Eans SO; Brice-Tutt AC; Cirino TJ; Stacy HM; Simons CA; León F; Sharma A; Boyer EW; Avery BA; McLaughlin JP; McCurdy CR
Drug Alcohol Depend; 2020 Nov; 216():108310. PubMed ID: 33017752
[TBL] [Abstract][Full Text] [Related]
6. Kratom and Future Treatment for the Opioid Addiction and Chronic Pain: Periculo Beneficium?
Ismail I; Wahab S; Sidi H; Das S; Lin LJ; Razali R
Curr Drug Targets; 2019; 20(2):166-172. PubMed ID: 28443503
[TBL] [Abstract][Full Text] [Related]
7. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
[TBL] [Abstract][Full Text] [Related]
8. Some pharmacological properties of a newly synthesized 3-acetoxy-6 beta-acetylthio-10-oxo-N-cyclopropylmethyl-dihydronormorphine (KT-95).
Hosoki R; Niizawa S; Koike K; Sagara T; Kanematsu K; Takayanagi I
Arch Int Pharmacodyn Ther; 1996; 331(2):136-52. PubMed ID: 8937625
[TBL] [Abstract][Full Text] [Related]
9. Chemical composition and biological effects of kratom (Mitragyna speciosa): In vitro studies with implications for efficacy and drug interactions.
Todd DA; Kellogg JJ; Wallace ED; Khin M; Flores-Bocanegra L; Tanna RS; McIntosh S; Raja HA; Graf TN; Hemby SE; Paine MF; Oberlies NH; Cech NB
Sci Rep; 2020 Nov; 10(1):19158. PubMed ID: 33154449
[TBL] [Abstract][Full Text] [Related]
10. The medicinal chemistry and neuropharmacology of kratom: A preliminary discussion of a promising medicinal plant and analysis of its potential for abuse.
Kruegel AC; Grundmann O
Neuropharmacology; 2018 May; 134(Pt A):108-120. PubMed ID: 28830758
[TBL] [Abstract][Full Text] [Related]
11. Mu-opioid receptors are not involved in acute cocaine-induced locomotor activity nor in development of cocaine-induced behavioral sensitization in mice.
Lesscher HM; Hordijk M; Bondar NP; Alekseyenko OV; Burbach JP; van Ree JM; Gerrits MA
Neuropsychopharmacology; 2005 Feb; 30(2):278-85. PubMed ID: 15257307
[TBL] [Abstract][Full Text] [Related]
12. Different effects of opioid antagonists on mu-, delta-, and kappa-opioid receptors with and without agonist pretreatment.
Wang D; Sun X; Sadee W
J Pharmacol Exp Ther; 2007 May; 321(2):544-52. PubMed ID: 17267582
[TBL] [Abstract][Full Text] [Related]
13. SoRI 9409, a non-peptide opioid mu receptor agonist/delta receptor antagonist, fails to stimulate [35S]-GTP-gamma-S binding at cloned opioid receptors.
Xu H; Lu YF; Rice KC; Ananthan S; Rothman RB
Brain Res Bull; 2001 Jul; 55(4):507-11. PubMed ID: 11543951
[TBL] [Abstract][Full Text] [Related]
14. Accelerated Solvent Extractions (ASE) of
Goh YS; Karunakaran T; Murugaiyah V; Santhanam R; Abu Bakar MH; Ramanathan S
Molecules; 2021 Jun; 26(12):. PubMed ID: 34204457
[No Abstract] [Full Text] [Related]
15. Synthetic and Receptor Signaling Explorations of the Mitragyna Alkaloids: Mitragynine as an Atypical Molecular Framework for Opioid Receptor Modulators.
Kruegel AC; Gassaway MM; Kapoor A; Váradi A; Majumdar S; Filizola M; Javitch JA; Sames D
J Am Chem Soc; 2016 Jun; 138(21):6754-64. PubMed ID: 27192616
[TBL] [Abstract][Full Text] [Related]
16. G protein-biased kratom-alkaloids and synthetic carfentanil-amide opioids as potential treatments for alcohol use disorder.
Gutridge AM; Robins MT; Cassell RJ; Uprety R; Mores KL; Ko MJ; Pasternak GW; Majumdar S; van Rijn RM
Br J Pharmacol; 2020 Apr; 177(7):1497-1513. PubMed ID: 31705528
[TBL] [Abstract][Full Text] [Related]
17. Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses.
Filliol D; Ghozland S; Chluba J; Martin M; Matthes HW; Simonin F; Befort K; Gavériaux-Ruff C; Dierich A; LeMeur M; Valverde O; Maldonado R; Kieffer BL
Nat Genet; 2000 Jun; 25(2):195-200. PubMed ID: 10835636
[TBL] [Abstract][Full Text] [Related]
18. Antinociceptive effect of 7-hydroxymitragynine in mice: Discovery of an orally active opioid analgesic from the Thai medicinal herb Mitragyna speciosa.
Matsumoto K; Horie S; Ishikawa H; Takayama H; Aimi N; Ponglux D; Watanabe K
Life Sci; 2004 Mar; 74(17):2143-55. PubMed ID: 14969718
[TBL] [Abstract][Full Text] [Related]
19. Changes in analgesia-producing mechanism of repeated cold stress loading in mice.
Omiya Y; Goto K; Ishige A; Komatsu Y
Pharmacol Biochem Behav; 2000 Feb; 65(2):261-6. PubMed ID: 10672978
[TBL] [Abstract][Full Text] [Related]
20. Endomorphin-1: induction of motor behavior and lack of receptor desensitization.
Mehta A; Bot G; Reisine T; Chesselet MF
J Neurosci; 2001 Jun; 21(12):4436-42. PubMed ID: 11404430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
